title: Complete response to crizotinib in a patient with adenocarcinoma of the lung cancer harboring c- MET amplification.
authors.affiliation: Department of Medical Oncology, Bakirkoy Dr. Sadi Konuk Education and Research Hospital, Istanbul, Turkey.
authors.forename: Ibrahim
authors.initials: I
authors.lastname: Cil
authors.forename: Alisan
authors.initials: A
authors.lastname: Zirtiloglu
authors.forename: Nurbanu
authors.initials: N
authors.lastname: Saydam
authors.forename: Deniz
authors.initials: D
authors.lastname: Tural
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000235:genetics; D000077192:Adenocarcinoma of Lung; D000368:Aged; D000077547:Crizotinib; D005784:Gene Amplification; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D019859:Proto-Oncogene Proteins c-met / Q000235:genetics*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D000077547:Crizotinib; D019859:Proto-Oncogene Proteins c-met